Gold and uranium were the major ASX commodities in the winners list in October, while coal and lithium prices continued ... Read More The post Up,...
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...
A Massachusetts campaign believes it has collected enough valid signatures to force lawmakers to consider a psychedelics legalization initiative—the...
As the psychedelic movement transforms and develops into a new entity, there is bound to be internal conflict and opposition. The fight to include indigenous...
OH legalization economic report; Feds back marijuana/cancer study; CA psychedelics ballot measure; Study: Traffic deaths drop in legal cannabis states...
The Daily Hit is a recap of the top financial news stories for Oct. 25, 2023. On the Site New Mexico Pursues Unpaid Taxes From Cannabis...
– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated...
Activists in California say they’ll submit a proposed ballot measure this week that would legalize the use, production and eventual sales of most psychedelics,...
Feds release redacted rescheduling letter; DEA agent fired for CBD seeks support; Speaker Johnson on marijuana; Malta cannabis licenses; KS poll Subscribe to...
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the United States Patent and Trademark Office has issued two patent grants that offer protection...